Corsicana & Co. Sarepta Therapeutics, Inc. Transaction History
Corsicana & Co.
- $119 Million
- Q3 2022
A detailed history of Corsicana & Co. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Corsicana & Co. holds 100 shares of SRPT stock, worth $1,820. This represents 0.01% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$1,820
Previous $7,000
57.14%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
508Shares Held
88.9MCall Options Held
1.39MPut Options Held
1.13M-
Black Rock Inc. New York, NY10.3MShares$188 Million0.04% of portfolio
-
Capital International Investors Los Angeles, CA9.06MShares$165 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.03MShares$164 Million0.01% of portfolio
-
State Street Corp Boston, MA4.07MShares$74 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$61.2 Million0.12% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.59B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...